Julia Stomper

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Combination Therapy

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Cancer research

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Stomper, Paulina Richter-Pechanska, Dietmar Pfeifer, Immacolata Andolfo, Achille Iolascon, Martina U Muckenthaler, Michael Lübbert
Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes. Blood advances 6 (11) (2022)
Ruth Meier, Gabriele Greve, Dennis Zimmer, Helena Bresser, Bettina Berberich, Ralitsa Langova, Julia Stomper, Anne Rubarth, Lars Feuerbach, Daniel B Lipka, Joschka Hey, Björn Grüning, Benedikt Brors, Justus Duyster, Christoph Plass, Heiko Becker, Michael Lübbert
The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation. Blood cancer journal 12 (8) (2022)
Julia Stomper, John Charles Rotondo, Gabriele Greve, Michael Lübbert
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies. Leukemia 35 (7) (2021)
Gabriele Greve, Julia Schueler, Björn A Grüning, Bettina Berberich, Julia Stomper, Dennis Zimmer, Lea Gutenkunst, Ulrike Bönisch, Ruth Meier, Nadja Blagitko-Dorfs, Olga Grishina, Dietmar Pfeifer, Dieter Weichenhan, Christoph Plass, Michael Lübbert
Decitabine Induces Gene Derepression on Monosomic Chromosomes: In Vitro and In Vivo Effects in Adverse-Risk Cytogenetics AML. Cancer research 81 (4) (2020)
Annette M May, Julia Stomper, Tina E Joeckel, Peter Bronsert, Pierre W Wijermans, Martin Werner, Michael Lübbert
Distinct bone marrow morphologic features discriminate myelodysplastic syndromes patients with and without an early platelet response to decitabine. British journal of haematology 189 (5) (2020)